ArticleExperimental and therapeutic medicine2023

Anti‑BCMA CAR‑T cell immunotherapy for relapsed or refractory multiple myeloma.

Xiaohui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.